International Clinical Trial: Phase 2 Study of AV-1959R in Individuals With Preclinical Alzheimer's Disease

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07827768) titled 'Phase 2 Study of AV-1959R in Individuals With Preclinical Alzheimer's Disease' on Sept. 14.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Double (Participant, Investigator).

Primary Sponsor: Institute for Molecular Medicine

Condition: Preclinical Alzheimer's Disease Alzheimer Disease

Intervention: Biological: AV-1959R

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: March 1, 2027

Target Sample Size: 160

To know more, visit https://clinicaltrials.gov/study/NCT07827768

Published ...